BFC Planning’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35K Buy
51
+27
+113% +$1.3K ﹤0.01% 2962
2026
Q2
$1.41K Hold
24
– – ﹤0.01% 3070
2026
Q1
$773 Sell
24
-10
-29% -$370 ﹤0.01% 2789
2025
Q4
$1.43K Buy
34
+2
+6% +$81 ﹤0.01% 2713
2025
Q3
$1.1K Hold
32
– – ﹤0.01% 2604
2025
Q2
$865 Buy
+32
New +$927 ﹤0.01% 2477

Other funds holding VCYT

BFC Planning's VCYT Position: Q3 2026 in Review

BFC Planning increased its Veracyte (VCYT) stake by 113% in Q3 2026, buying an estimated $1.3K and bringing the position to 51 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

BFC Planning first reported a position in VCYT in Q2 2025 and has held it in 6 quarters since. 300 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • BFC Planning held 51 shares of Veracyte worth $2.35K as of Q3 2026.
  • BFC Planning bought 27 Veracyte shares in Q3 2026, an estimated $1.3K.
  • Veracyte made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2962 holding.
  • BFC Planning first reported a position in Veracyte in Q2 2025 and has held it in 6 quarters since.
  • 300 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.